|
KIAA1919 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.99200722162641E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07089995047016E-09 |
| Normal-vs-Stage2 |
1.555360E-03 |
| Normal-vs-Stage3 |
2.941800E-03 |
| Normal-vs-Stage4 |
5.403800E-02 |
| Stage1-vs-Stage2 |
9.020000E-02 |
| Stage1-vs-Stage3 |
1.898030E-01 |
| Stage1-vs-Stage4 |
5.499000E-01 |
| Stage2-vs-Stage3 |
9.388800E-01 |
| Stage2-vs-Stage4 |
6.359400E-01 |
| Stage3-vs-Stage4 |
6.555200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.85484960724125E-12 |
| Normal-vs-AfricanAmerican |
5.93650000046964E-07 |
| Normal-vs-Asian |
5.621400E-01 |
| Caucasian-vs-AfricanAmerican |
8.082400E-01 |
| Caucasian-vs-Asian |
2.443200E-01 |
| AfricanAmerican-vs-Asian |
2.061400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62492241884138E-12 |
| Normal-vs-Female |
9.8617000000023E-05 |
| Male-vs-Female |
2.263800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.840100E-04 |
| Normal-vs-Extreme_Weight |
4.98280000005291E-06 |
| Normal-vs-Obese |
3.09839998102746E-09 |
| Normal-vs-Extreme_Obese |
1.703980E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.847600E-01 |
| Normal_Weight-vs-Obese |
2.341800E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.796200E-02 |
| Extreme_Weight-vs-Obese |
1.065730E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.137700E-02 |
| Obese-vs-Extreme_Obese |
5.502200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.816900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.66378022470326E-12 |
| Normal-vs-Age(61-80Yrs) |
3.47649999898891E-08 |
| Normal-vs-Age(81-100Yrs) |
7.543900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.579000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.583600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.735590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.064300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.078900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.696790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63746793901964E-12 |
| Normal-VS-Type2 PRCC |
1.91119999999323E-05 |
| Normal-VS-KIRP CIMP |
2.915700E-02 |
| Normal-VS-Unclassified PRCC |
4.426500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.727600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.047200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.219000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.257600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.983400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.920000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.772600E-04 |
| Normal-vs-N1 |
2.815600E-03 |
| Normal-vs-N2 |
3.215400E-01 |
| N0-vs-N1 |
1.026580E-01 |
| N0-vs-N2 |
7.698200E-01 |
| N1-vs-N2 |
5.983200E-01 |
|
|
